Impero (IMPERO) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
15 Apr, 2026Opening remarks and agenda
General meeting was lawfully convened and decision-making authority confirmed, with 85.22% of share capital represented.
Agenda included standard statutory items and three board proposals, all eligible for approval.
Financial performance review
Achieved 19% growth in annual recurring revenue (ARR), reaching DKK 46.2 million by year-end 2025.
EBITDA improved from -DKK 8.7 million in 2024 to -DKK 3.1 million in 2025, driven by revenue growth and cost control.
Cash position strengthened to DKK 18.9 million after a directed share issue in December 2025.
Churn rate was exceptionally low at 1%, with net uplift from existing customers at 7%.
Deferred income increased due to higher activity and upfront customer payments; no interest-bearing debt.
Strategic initiatives and plans
Continued investment in platform functionality, especially AI-driven features, to support compliance processes.
Expansion focus on DACH and Nordwesteuropean markets, with DACH leading new ARR generation.
Cash flow positivity target postponed to prioritize growth and long-term shareholder value.
Commercial investments and organizational discipline enhanced to drive sales momentum.
Latest events from Impero
- 28% ARR and 29% revenue growth, improved EBITDA, and strong DACH expansion in H1 2024.IMPERO
Q2 202427 Jul 2026 - 31% ARR growth, strong retention, and positive cash flow highlight robust Q3 performance.IMPERO
Q3 202427 Jul 2026 - 28% ARR growth, improved EBITDA, and reduced churn set the stage for strong 2025 guidance.IMPERO
Q4 202427 Jul 2026 - 24% ARR growth, 27% revenue rise, and strong retention highlight robust Q1 2025 performance.IMPERO
Q1 202527 Jul 2026 - ARR up 15% to DKK 40.7M, revenue up 21%, EBITDA loss narrows, guidance maintained.IMPERO
Q2 202527 Jul 2026 - Record ARR growth, positive EBITDA, and strong DACH performance drive raised 2025 outlook.IMPERO
Q3 202527 Jul 2026 - ARR grew 19% to DKK 46.2M in 2025, with EBITDA improving and churn at a low 1%.IMPERO
Q4 202527 Jul 2026 - 20% ARR growth, positive EBITDA, and strong DACH momentum drive upgraded 2026 outlook.IMPERO
Q1 202627 Jul 2026 - Entity Management, AI features, and Control Health drive upcoming platform enhancements.IMPERO
Investor update24 Jun 2026